PER 0.00% 8.1¢ percheron therapeutics limited

Quarterly Update & Appendix 4C• Type C meeting granted with US...

  1. 1,055 Posts.
    lightbulb Created with Sketch. 145
    Quarterly Update & Appendix 4C
    • Type C meeting granted with US FDA to discuss ATL1102 in DMD
    • Paediatric Investigation Plan for ATL1102 in DMD submitted to EMA
    • Manufacture of clinical supplies in progress
    • Dr Charmaine Gittleson appointed as a Non-Executive Director
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $47.41K 578.2K

Buyers (Bids)

No. Vol. Price($)
3 142694 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 104529 2
View Market Depth
Last trade - 14.00pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.